RAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML020116

FDA Device Recall #Z-0155-2027 - Class II, September 21, 2026

Recall Summary

Recall Number Z-0155-2027
Classification Class II - Moderate risk
Date Initiated September 21, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Steris Corporation
Location Mentor, OH
Product Type Devices
Quantity 11806 units

Product Description

RAPICIDE PA Part A High-Level Disinfectant, Model/Catalog Number: ML020116

Reason for Recall

If the vented cap becomes blocked, gas may accumulate and the bottle may swell due to increased internal pressure. In some cases, excess vapor or liquid chemistry may escape from the bottle when the cap is twisted during opening, which could result in user exposure if required personal protective equipment (PPE) is not properly used. Such exposure may result in injury to the user or others in close proximity.

Distribution Pattern

Worldwide - US Nationwide distribution.

Lot / Code Information

UDI: 00724995245955 Lot numbers with expiration dates: 689171 5/4/2027 689981 5/12/2027 690993 5/26/2027 691739 6/2/2027 692570 6/11/2027 694357 7/1/2027

Other Recalls from Steris Corporation

Recall # Classification Product Date
Z-0118-2027 Class II HexaVue Focus Integration System, a single, all... Sep 23, 2026
Z-0156-2027 Class II RAPICIDE PA Part A High-Level Disinfectant, Mod... Sep 21, 2026
Z-0154-2027 Class II RAPICIDE PA Part A High-Level Disinfectant, Mod... Sep 21, 2026
Z-0074-2027 Class II VERIFY Biological Steam Test Pack Model/Catalo... Aug 31, 2026
Z-0072-2027 Class II VERIFY Dual Species Self-Contained Biological I... Aug 31, 2026

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.